World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01083004
Date of registration: 08/03/2010
Primary sponsor: University of Cologne
Public title: Brilliant Blue Versus Indocyanine Green
Scientific title: A Randomized Study Comparing Brilliant Blue and Indocyanine Green as Intravitreal Dye in Macular Pucker and Macular Hole
Date of first enrolment: January 2008
Target sample size: 50
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01083004
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
Germany
Contacts
Name:   Albert Caramoy, MD
Address: 
Telephone: 004902214784308
Email: acaramoy@yahoo.co.uk
Affiliation: 
Name:   Albert Caramoy, MD
Address: 
Telephone: 004902214784308
Email: acaramoy@yahoo.co.uk
Affiliation: 
Name:   Bernd Kirchhof, MD
Address: 
Telephone:
Email:
Affiliation:  University of Cologne, Center of Ophthalmology, 50924 Cologne, Germany
Key inclusion & exclusion criteria

Inclusion Criteria:

- age over 50

- macular pucker or macular hole with subjective disturbances

- All phakic or pseudophakic patients

- far visual acuity better than 20/400

- able to read, understand, and willing to sign the informed consent form

Exclusion Criteria:

- any other ocular disease or conditions compromising the visual acuity other than
macular hole or macular pucker

- prior vitreoretinal surgery in the study eye



Age minimum: 50 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Macular Hole
Macular Pucker
Vitreoretinal Surgery
Intervention(s)
Procedure: Brilliant blue arm
Procedure: Indocyanine green
Primary Outcome(s)
Best corrected far visual acuity (ETDRS) [Time Frame: 1 year postoperative]
Secondary Outcome(s)
Optical coherence tomography [Time Frame: 1 year]
Reading ability (Radner) [Time Frame: 1 Year]
Secondary ID(s)
BlueIce001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history